Tartary buckwheat D-chiral-inositol composite hypoglycemic tablet and preparation method thereof

A technology of chiral inositol and compound tablets, which is applied in drug combinations, pharmaceutical formulas, organic active ingredients, etc., can solve the problems of high side effects of hypoglycemic drugs, difficulty in curing, liver and spleen and stomach damage, etc., and achieve weight improvement , good therapeutic effect, the effect of scientific ratio

Inactive Publication Date: 2019-10-15
HARBIN INST OF TECH
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current treatment of diabetes is limited to the remission of symptoms, it is difficult to achieve a cure level, and the side effects of related hypoglycemic drugs are relatively large, and long-term use can cause certain damage to the liver and spleen and stomach

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] A preparation method of tartary buckwheat D-chiro-inositol compound hypoglycemic compressed tablet, the steps are as follows:

[0052] 1. Selection of raw materials: select fresh and pest-free raw materials for use;

[0053] 2. Pretreatment: Dry each raw and auxiliary material in a 40°C constant temperature drying oven, ultrafinely pulverize, and pass through a 80-mesh sieve;

[0054] 3. Tartary buckwheat D-chiro-inositol extraction: Three-dimensional ultrasonic extraction technology is used to extract tartary buckwheat D-chiro-inositol. After single factor and orthogonal experiments, the best extraction conditions are: 50% ethanol extraction, The ratio of solid to liquid is 1:10~30, the ultrasonic temperature is 50°C, the ultrasonic time is 30min, the power is 400W, and it is concentrated until the water content is lower than 15%;

[0055] 4. Extraction of active ingredients of bitter gourd: three-dimensional ultrasonic extraction technology is used to extract the act...

Embodiment 2

[0067] A preparation method of tartary buckwheat D-chiro-inositol compound hypoglycemic compressed tablet, the steps are as follows:

[0068] 1. Selection of raw materials: select fresh and pest-free raw materials for use;

[0069] 2. Pretreatment: Dry each raw and auxiliary material in a 40°C constant temperature drying oven, ultrafinely pulverize, and pass through a 80-mesh sieve;

[0070] 3. Tartary buckwheat D-chiro-inositol extraction: Three-dimensional ultrasonic extraction technology is used to extract tartary buckwheat D-chiro-inositol. After single factor and orthogonal experiments, the best extraction conditions are: 50% ethanol extraction, The ratio of solid to liquid is 1:10~30, the ultrasonic temperature is 50°C, the ultrasonic time is 30min, the power is 400W, and it is concentrated until the water content is lower than 15%;

[0071] 4. Extraction of active ingredients of cassia seeds: three-dimensional ultrasonic extraction technology is used to extract active ...

Embodiment 3

[0084] A preparation method of tartary buckwheat D-chiro-inositol compound hypoglycemic compressed tablet, the steps are as follows:

[0085] 1. Selection of raw materials: select fresh and pest-free raw materials for use;

[0086] 2. Pretreatment: Dry each raw and auxiliary material in a 40°C constant temperature drying oven, ultrafinely pulverize, and pass through a 80-mesh sieve;

[0087] 3. Tartary buckwheat D-chiro-inositol extraction: Three-dimensional ultrasonic extraction technology is used to extract tartary buckwheat D-chiro-inositol. After single factor and orthogonal experiments, the best extraction conditions are: 50% ethanol extraction, The ratio of solid to liquid is 1:10~30, the ultrasonic temperature is 50°C, the ultrasonic time is 30min, the power is 400W, and it is concentrated until the water content is lower than 15%;

[0088] 4. Extraction of active components of American ginseng: The active components of American ginseng were extracted using three-dimen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
thicknessaaaaaaaaaa
Login to view more

Abstract

The invention discloses a tartary buckwheat D-chiral-inositol composite hypoglycemic tablet and a preparation method thereof. The tartary buckwheat D-chiral-inositol composite hypoglycemic tablet is prepared from the following original auxiliary materials in percentage: 15-30% of tartary buckwheat D-chiral-inositol concentrated solution, 3-5% of bitter gourd concentrated solution, 3-5% of mulberryconcentrated solution, 3-7% of cassia obtusifolia concentrated solution, 3-7% of american ginseng concentrated solution, 3-7% of orange peel concentrated solution, 3-5% of honeysuckle concentrated solution, 4-8% of the root of kudzu vine concentrated solution, 4-8% of astragalus membranaceus concentrated solution, 7-14% of purslane fungistat, 6-10% of pumpkin polysaccharide, 6-13% of black funguspolysaccharide, 7-16% of soybean hypoglycemic peptide, 3-20% of xylitol, 3-10% of maltitol, 0.3-0.8% of citric acid, 3.4-8.7% of beta-cyclodextrine, and 0.5-1% of magnesium stearate. The tartary buckwheat D-chiral-inositol composite hypoglycemic tablet has the characteristic that tartary buckwheat extracts with high content of D-chiral-inositol are used as raw materials to prepare a composite tablet with the hypoglycemic effect. The tartary buckwheat D-chiral-inositol composite hypoglycemic table takes natural plant hypoglycemic active ingredients as the original auxiliary materials and a purslane active ingredient as a natural antibacterial agent, and is safe, reliable and edible.

Description

technical field [0001] The invention relates to the technical field of health food, and is a tablet with hypoglycemic effect prepared from tartary buckwheat D-chiro-inositol. Background technique [0002] Diabetes can be divided into type I diabetes, type II diabetes, gestational diabetes and other types of diabetes due to its different pathogenesis, among which type II diabetes patients account for about 90%, and these patients have attracted much attention. However, the current treatment of diabetes is only limited to the remission stage of symptoms, and it is difficult to reach the level of cure, and the related hypoglycemic drugs have relatively large side effects, and long-term use can cause certain damage to the liver and spleen and stomach. The development of hypoglycemic drugs with good efficacy and few side effects for the treatment of diabetes has become a worldwide problem to be solved urgently. Relevant studies have found that active ingredients such as flavonoi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/105A23L33/125A23L33/10A61K38/01A61P3/10
CPCA23L33/105A23L33/125A23L33/10A61K36/70A61K36/42A61K36/605A61K36/482A61K36/258A61K36/752A61K36/355A61K36/488A61K36/481A61K36/185A61K31/715A61K38/011A61P3/10A23V2002/00
Inventor 王振宇赵梦雅韩晓旭王佳慧
Owner HARBIN INST OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap